AMPX vs RCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

AMPX

36.8
AI Score
VS
RCAT Wins

RCAT

38.5
AI Score

Investment Advisor Scores

AMPX

37score
Recommendation
SELL

RCAT

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric AMPX RCAT Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 125.9% 527.2% RCAT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.8/100 38.5/100 RCAT
Profit Margin -33.4% -136.3% AMPX
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

AMPX 1M: +4.3% · 3M: -32.4% RCAT 1M: +19.8% · 3M: +6.5%

Current Technical Phase

AMPX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.2%), weak momentum, RSI 43

RSI (14): 42.8 · Price: $10.34

RCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.0 · Price: $9.62

Fundamentals Snapshot

Metric AMPX RCAT
Market Cap
Forward P/E 103.4 -32.1
Trailing P/E
Revenue (TTM)
Revenue Growth 1.3% 5.3%
Gross Margin 0.2% 0.1%
Operating Margin -0.1% -1.9%
EPS -0.28 -0.77
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.